DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/6zmtmq/next_generation) has announced the addition of the "Next Generation Sequencing (NGS) Market by Platforms, Bioinformatics , Technology & by Application - Global Forecast to 2020" report to their offering.
The global next generation sequencing market is dynamic and witnessing many changes with new products being introduced. The global NGS market will be worth $2.5 billion in 2014 and is poised to reach $8.7 billion by 2020.
The NGS market segments such as pre-sequencing products and services, NGS platforms, sequencing services and data analysis/bioinformatics are rapidly growing markets. The overall NGS market is flourishing by continuous innovations and developments in the market aimed at higher throughput, increased accuracy, and affordable costs. Developments in the pre-sequencing, cloud computing, and NGS bioinformatics solutions are major opportunities for this market.
NGS services market is one of the key segments in the NGS market which is estimated to grow at a CAGR of 24.0% by 2020. The growth is driven by increasing demand in diagnostics and pharmaceutical and biotechnology companies.
Sequencing by Synthesis technology will be the fastest growing technology in the coming years. SBS technology has wide applications in the NGS market and can be used for both single read and pair end libraries. Hence the demand for platforms such as HiSeq X Ten, NextSeq 500 and MiSeq is also high.
Presequencing products and services market will also witness high growth and is estimated to grow at 23.5% CAGR in the next six years. The growth can be attributed to the increasing demand for presequencing consumables and instruments as the quality of the end product depends on the presequencing treatment. The growing need for standardized sample preparation solutions and increasing automation in the pre-sequencing workflow step are drivers of this market.
The study is confined to platforms, consumables and services provided by top 4 companies, Illumina, Thermo Fisher (Life Technologies), Roche and Pacific Biosciences. It does not include other NGS platforms and miscellaneous consumables/reagents offered by other companies. Also, market estimation does not consider upcoming technologies or platforms.
- Illumina HiSeq
- HiSeqX Ten
- NextSeq 500
- Thermo Fisher Ion Proton/PGM
- Exome Sequencing
- Personalized Medicine
- 454 Life Sciences Corporation (Roche Holding Ag)
- Agilent Technologies, Inc.
- Bgi (Beijing Genomics Institute)
- Biomatters, Ltd.
- Clc Bio (Acquired By Qiagen)
- Dnastar, Inc.
- Gatc Biotech Ag
- Genomatix Software Gmbh
- Illumina, Inc.
- Knome, Inc.
- Life Technologies Corporation (Thermo Fisher Scientific)
- Macrogen, Inc.
- Oxford Nanopore Technologies, Ltd.
- Pacific Biosciences
- Partek Incorporated
- Perkin Elmer, Inc.
- Qiagen N.V.
For more information visit http://www.researchandmarkets.com/research/6zmtmq/next_generation